US HB456 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 24 2023 - 25% progression
Action: 2023-02-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 24 2023 - 25% progression
Action: 2023-02-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
Title
Fairness in Orphan Drug Exclusivity Act
Sponsors
Rep. Earl Carter [R-GA] |
History
Date | Chamber | Action |
---|---|---|
2023-02-03 | House | Referred to the Subcommittee on Health. |
2023-01-24 | House | Referred to the House Committee on Energy and Commerce. |
2023-01-24 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/456/all-info |
Text | https://www.congress.gov/118/bills/hr456/BILLS-118hr456ih.pdf |